97 companies

Maxigen Biotech

Market Cap: NT$4.0b

Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.

1783

NT$45.80

7D

-0.1%

1Y

1.0%

Formosa Pharmaceuticals

Market Cap: NT$4.8b

A clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan.

6838

NT$32.30

7D

3.2%

1Y

-39.4%

PhytoHealth

Market Cap: NT$3.2b

Researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and dietary supplements in Taiwan.

4108

NT$15.85

7D

-0.9%

1Y

-21.9%

Eusol BiotechLtd

Market Cap: NT$1.1b

Focuses on research and development of new biotech drugs for sleep disorders.

6652

NT$7.80

7D

-1.1%

1Y

-12.8%

TCM Biotech International

Market Cap: NT$3.3b

A biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases.

4169

NT$57.10

7D

-1.2%

1Y

8.6%

HeXun Biosciences

Market Cap: NT$3.7b

Engages in the research and development of stem cell and treatments in Taiwan.

6986

NT$81.00

7D

-6.0%

1Y

47.3%

Advagene Biopharma

Market Cap: NT$1.3b

Engages in the research and development of vaccine technology and related products in Taiwan.

6709

NT$21.40

7D

-2.7%

1Y

9.7%

EirGenix

Market Cap: NT$23.2b

Operates as a contract development and manufacturing company in Taiwan and internationally.

6589

NT$77.70

7D

0.6%

1Y

-9.2%

Shine-On BioMedicalLtd

Market Cap: NT$3.3b

Research, develops, and manufactures anti-cancer related drug products.

6926

NT$65.20

7D

0.6%

1Y

0.5%

PharmaEngine

Market Cap: NT$15.2b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

4162

NT$104.50

7D

-1.9%

1Y

8.0%

Synmosa Biopharma

Market Cap: NT$14.4b

A specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan.

4114

NT$34.15

7D

0%

1Y

-3.2%

CHO Pharma

Market Cap: NT$11.4b

Engages in research and development of biotechnology in Taiwan.

6586

NT$53.20

7D

-2.2%

1Y

-10.0%

Savior Lifetec

Market Cap: NT$6.5b

A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.

4167

NT$20.80

7D

2.2%

1Y

8.9%

BIONET Therapeutics

Market Cap: NT$3.7b

A biopharmaceutical company, develops cell therapy products and drug development for acute and severe diseases.

7808

NT$53.50

7D

-2.7%

1Y

n/a

ScinoPharm Taiwan

Market Cap: NT$17.9b

Research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, India, the United States and internationally.

1789

NT$22.50

7D

-2.0%

1Y

-13.6%

Sinew Pharma

Market Cap: NT$3.5b

A biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases.

6634

NT$49.60

7D

1.2%

1Y

-26.1%

Oneness Biotech

Market Cap: NT$34.4b

Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products primarily in Taiwan.

4743

NT$72.20

7D

-3.9%

1Y

-55.7%

Ever Supreme Bio Technology

Market Cap: NT$14.6b

Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells.

6712

NT$176.50

7D

-0.8%

1Y

-8.8%

Alar Pharmaceuticals

Market Cap: NT$9.8b

A drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan.

6785

NT$146.50

7D

0%

1Y

-51.3%

TaiwanJ Pharmaceuticals

Market Cap: NT$726.7m

A specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan.

6549

NT$9.12

7D

1.0%

1Y

-32.9%

Lukas Biomedical

Market Cap: NT$1.1b

Engages in the wholesale and retail of cosmetics in Taiwan.

6814

NT$25.50

7D

1.2%

1Y

-17.7%

Standard Chemical & Pharmaceutical

Market Cap: NT$11.3b

Standard Chemical & Pharmaceutical Co. Ltd.

1720

NT$62.70

7D

-0.6%

1Y

-3.8%

PharmaEssentia

Market Cap: NT$186.5b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

6446

NT$564.00

7D

-0.4%

1Y

77.4%

BRIM Biotechnology

Market Cap: NT$3.7b

A clinical-stage company, engages in the development of novel regenerative therapies to combat and cure ophthalmology and degenerative joint diseases.

6885

NT$28.10

7D

-3.6%

1Y

-17.2%

TaiRx

Market Cap: NT$3.0b

Focuses on the development and commercialization of therapeutics for the treatment of cancer and other diseases.

6580

NT$25.75

7D

-7.9%

1Y

1.8%

Vectorite Biomedical

Market Cap: NT$595.3m

Engages in the research and development of biotechnology in Taiwan and internationally.

4170

NT$13.45

7D

-1.5%

1Y

-14.9%

Senhwa Biosciences

Market Cap: NT$3.7b

A drug development company, engages in the development of new drugs and targeted agents.

6492

NT$41.55

7D

-2.2%

1Y

-3.5%

GlycoNex Incorporation

Market Cap: NT$2.6b

Engages in the development of cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies in Taiwan.

4168

NT$23.85

7D

-1.0%

1Y

-3.0%

Pharmosa Biopharm

Market Cap: NT$7.0b

A biotechnology company, focuses on developing drugs in Taiwan.

6875

NT$53.40

7D

0.8%

1Y

-42.0%

Medigen Vaccine Biologics

Market Cap: NT$17.7b

A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.

6547

NT$53.80

7D

-3.9%

1Y

3.5%

DV Biomed

Market Cap: NT$1.4b

Manufactures and sells medical-grade skin care products in Taiwan and China.

6539

NT$66.00

7D

3.8%

1Y

-49.5%

Abnova (Taiwan)

Market Cap: NT$1.8b

Manufactures and sells various recombinant proteins and antibodies.

4133

NT$30.05

7D

0.3%

1Y

-5.9%

Lumosa Therapeutics

Market Cap: NT$34.5b

A clinical-stage pharmaceutical company, develops therapies and solutions for neurological and oncological diseases in Taiwan, Asia, the Americas, and Europe.

6535

NT$205.50

7D

-1.9%

1Y

14.2%

UnicoCell Biomed

Market Cap: NT$4.1b

Engages in the research and development of stem cell drugs, cell therapy technology, and regenerative medical services in Taiwan.

6794

NT$70.00

7D

-1.3%

1Y

-19.5%

YungShin Global Holding

Market Cap: NT$15.0b

Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics in Taiwan, the United States, Mainland China, and Japan.

3705

NT$55.50

7D

-1.2%

1Y

16.5%

SynCore BiotechnologyLtd

Market Cap: NT$1.2b

Engages in development and sale of food advisory, medicine inspection, and biotechnology service in Taiwan.

4192

NT$33.90

7D

-1.5%

1Y

-9.5%

Page 1 of 3